Jiangxi Synergy Pharmaceutical Hits Day High with 7.82% Intraday Surge

Jiangxi Synergy Pharmaceutical Co., Ltd. has experienced a notable increase of 7.82% on June 23, 2026, reaching an intraday high of CNY 7.24. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.37% on the same day. Over the past week, Jiangxi Synergy has shown a positive trend, with a gain of 6.35%, while the Shanghai Composite managed only a slight increase of 0.35%. However, the company's longer-term performance reveals challenges, with a year-to-date decline of 6.39% and a significant drop of 41.56% over the past three years. Despite being net-debt free, Jiangxi Synergy has faced difficulties in achieving sustainable growth, as evidenced by a negative operating profit growth rate of 8.79% over the last five years. The company reported a net profit of CNY 7.9 million, reflecting a decline of 74.95%. With a market capitalization of CNY 1,179 million, Jiangxi Synergy continues to navigate a competitive landscape in the pharmaceuticals and biotechnology sector.